| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BPMC | Common Stock | Award | $0 | +6.51K | +43.47% | $0.00 | 21.5K | Mar 1, 2025 | Direct | F1 |
| transaction | BPMC | Common Stock | Sale | -$69.5K | -775 | -3.61% | $89.63 | 20.7K | Mar 3, 2025 | Direct | F2, F3 |
| transaction | BPMC | Common Stock | Sale | -$21.6K | -238 | -1.15% | $90.92 | 20.5K | Mar 3, 2025 | Direct | F2, F4 |
| transaction | BPMC | Common Stock | Sale | -$58.1K | -631 | -3.08% | $92.00 | 19.8K | Mar 3, 2025 | Direct | F2, F5 |
| transaction | BPMC | Common Stock | Sale | -$45.2K | -484 | -2.44% | $93.42 | 19.3K | Mar 3, 2025 | Direct | F2, F6 |
| transaction | BPMC | Common Stock | Sale | -$102K | -1.08K | -5.56% | $95.16 | 18.3K | Mar 3, 2025 | Direct | F2, F7 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BPMC | Stock Option (Right to Buy) | Award | $670K | +7.01K | $95.67 | 7.01K | Mar 1, 2025 | Common Stock | 7.01K | $96.57 | Direct | F1, F8 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | The reported transaction involved the Reporting Person's receipt of a grant of 6,506 restricted stock units under the Issuer's 2024 Stock Incentive Plan. |
| F2 | Effected pursuant to a trading plan adopted on September 12, 2024 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. |
| F3 | The price reported is an average sale price. The shares were sold in multiple transactions ranging from $89.34 to $90.14. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F4 | The price reported is an average sale price. The shares were sold in multiple transactions ranging from $90.36 to $91.21. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F5 | The price reported is an average sale price. The shares were sold in multiple transactions ranging from $91.45 to $92.42. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F6 | The price reported is an average sale price. The shares were sold in multiple transactions ranging from $93.03 to $93.95. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F7 | The price reported is an average sale price. The shares were sold in multiple transactions ranging from $95.15 to $95.36. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F8 | This option vests with respect to 1/48th of the shares underlying the option on April 1, 2025 and as to an additional 1/48th of the shares underlying the option each month thereafter. |